

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.90150254 |
| 2 | rRNA modification (GO:0000154) | 5.62357022 |
| 3 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.62079974 |
| 4 | maintenance of protein location in nucleus (GO:0051457) | 5.61145936 |
| 5 | rRNA methylation (GO:0031167) | 5.58643148 |
| 6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.56105838 |
| 7 | protein localization to kinetochore (GO:0034501) | 5.55039330 |
| 8 | cullin deneddylation (GO:0010388) | 5.33861037 |
| 9 | somite rostral/caudal axis specification (GO:0032525) | 5.33770907 |
| 10 | negative regulation of epidermis development (GO:0045683) | 5.33469829 |
| 11 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.32826166 |
| 12 | cytidine deamination (GO:0009972) | 5.31641038 |
| 13 | cytidine metabolic process (GO:0046087) | 5.31641038 |
| 14 | cytidine catabolic process (GO:0006216) | 5.31641038 |
| 15 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.21858901 |
| 16 | rRNA transcription (GO:0009303) | 5.07884664 |
| 17 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.03292937 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 5.02374411 |
| 19 | negative regulation of telomerase activity (GO:0051974) | 5.00199970 |
| 20 | proteasome assembly (GO:0043248) | 4.99990873 |
| 21 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.99698365 |
| 22 | protein deneddylation (GO:0000338) | 4.87926330 |
| 23 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.85036060 |
| 24 | DNA replication checkpoint (GO:0000076) | 4.81856490 |
| 25 | regulation of response to osmotic stress (GO:0047484) | 4.80694680 |
| 26 | mitotic sister chromatid segregation (GO:0000070) | 4.77912294 |
| 27 | regulation of cilium movement (GO:0003352) | 4.74327276 |
| 28 | quinone metabolic process (GO:1901661) | 4.74009408 |
| 29 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.65257510 |
| 30 | respiratory electron transport chain (GO:0022904) | 4.58443772 |
| 31 | phenol-containing compound catabolic process (GO:0019336) | 4.51339847 |
| 32 | regulation of translation in response to stress (GO:0043555) | 4.49116660 |
| 33 | electron transport chain (GO:0022900) | 4.48287890 |
| 34 | regulation of mitochondrial translation (GO:0070129) | 4.46602496 |
| 35 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.45594699 |
| 36 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.38572977 |
| 37 | protein complex biogenesis (GO:0070271) | 4.37906594 |
| 38 | DNA damage response, detection of DNA damage (GO:0042769) | 4.30384238 |
| 39 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.28289914 |
| 40 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.28289914 |
| 41 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.27817413 |
| 42 | GDP-mannose metabolic process (GO:0019673) | 4.24010586 |
| 43 | muscle organ morphogenesis (GO:0048644) | 4.23410623 |
| 44 | histone H4-K8 acetylation (GO:0043982) | 4.22876377 |
| 45 | histone H4-K5 acetylation (GO:0043981) | 4.22876377 |
| 46 | negative regulation of telomere maintenance (GO:0032205) | 4.22602276 |
| 47 | ribosomal small subunit biogenesis (GO:0042274) | 4.19981704 |
| 48 | histone H4-K12 acetylation (GO:0043983) | 4.18990857 |
| 49 | protein localization to chromosome, centromeric region (GO:0071459) | 4.18472438 |
| 50 | ribosome biogenesis (GO:0042254) | 4.08896011 |
| 51 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.07439691 |
| 52 | formation of translation preinitiation complex (GO:0001731) | 4.06927425 |
| 53 | protein targeting to mitochondrion (GO:0006626) | 4.04363282 |
| 54 | pseudouridine synthesis (GO:0001522) | 4.04296115 |
| 55 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.87435736 |
| 56 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.82156564 |
| 57 | nucleoside transmembrane transport (GO:1901642) | 3.81830158 |
| 58 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.81193856 |
| 59 | termination of RNA polymerase III transcription (GO:0006386) | 3.80240978 |
| 60 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.80240978 |
| 61 | respiratory chain complex IV assembly (GO:0008535) | 3.78545463 |
| 62 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.77811907 |
| 63 | ribosome assembly (GO:0042255) | 3.77228390 |
| 64 | coenzyme catabolic process (GO:0009109) | 3.77115300 |
| 65 | protein localization to mitochondrion (GO:0070585) | 3.77084795 |
| 66 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.75918191 |
| 67 | establishment of protein localization to mitochondrion (GO:0072655) | 3.73910257 |
| 68 | notochord development (GO:0030903) | 3.72253118 |
| 69 | sister chromatid segregation (GO:0000819) | 3.71171009 |
| 70 | maturation of SSU-rRNA (GO:0030490) | 3.68426126 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.67744768 |
| 72 | negative regulation of ligase activity (GO:0051352) | 3.67744768 |
| 73 | oxidative phosphorylation (GO:0006119) | 3.65390284 |
| 74 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.64502125 |
| 75 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.62225742 |
| 76 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.62225742 |
| 77 | heterochromatin organization (GO:0070828) | 3.61061327 |
| 78 | chromatin remodeling at centromere (GO:0031055) | 3.60425783 |
| 79 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.58370859 |
| 80 | DNA double-strand break processing (GO:0000729) | 3.57788352 |
| 81 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.57560173 |
| 82 | protein neddylation (GO:0045116) | 3.56647175 |
| 83 | transcription from mitochondrial promoter (GO:0006390) | 3.55558223 |
| 84 | CENP-A containing nucleosome assembly (GO:0034080) | 3.51737773 |
| 85 | regulation of telomerase activity (GO:0051972) | 3.48164647 |
| 86 | cytochrome complex assembly (GO:0017004) | 3.46570521 |
| 87 | interferon-gamma production (GO:0032609) | 3.44903278 |
| 88 | peptidyl-histidine modification (GO:0018202) | 3.44846224 |
| 89 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.44397485 |
| 90 | response to dietary excess (GO:0002021) | 3.43725496 |
| 91 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.42098859 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.40961057 |
| 93 | ribosomal small subunit assembly (GO:0000028) | 3.39704905 |
| 94 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.37259963 |
| 95 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.37107101 |
| 96 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.37107101 |
| 97 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.37107101 |
| 98 | spliceosomal snRNP assembly (GO:0000387) | 3.36540964 |
| 99 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.34707526 |
| 100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.33874365 |
| 101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.33874365 |
| 102 | primitive streak formation (GO:0090009) | 3.28258292 |
| 103 | cellular component biogenesis (GO:0044085) | 3.27890766 |
| 104 | cardiovascular system development (GO:0072358) | 3.26243558 |
| 105 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.26007437 |
| 106 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.26007437 |
| 107 | hormone catabolic process (GO:0042447) | 3.23640529 |
| 108 | translation (GO:0006412) | 3.23057703 |
| 109 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.22256238 |
| 110 | chromatin assembly (GO:0031497) | 3.21548328 |
| 111 | intestinal epithelial cell development (GO:0060576) | 3.20987527 |
| 112 | positive regulation of ligase activity (GO:0051351) | 3.19976676 |
| 113 | ubiquinone biosynthetic process (GO:0006744) | 3.16885842 |
| 114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.16507579 |
| 115 | ATP synthesis coupled proton transport (GO:0015986) | 3.16507579 |
| 116 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.14865043 |
| 117 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.14332081 |
| 118 | maturation of 5.8S rRNA (GO:0000460) | 3.13478468 |
| 119 | mitochondrial RNA metabolic process (GO:0000959) | 3.13081764 |
| 120 | protein polyglutamylation (GO:0018095) | 3.11844679 |
| 121 | mitochondrial transport (GO:0006839) | 3.09555193 |
| 122 | rRNA metabolic process (GO:0016072) | 3.09438311 |
| 123 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.07023303 |
| 124 | inner mitochondrial membrane organization (GO:0007007) | 3.06800129 |
| 125 | ribosomal large subunit biogenesis (GO:0042273) | 3.05436273 |
| 126 | purine nucleobase biosynthetic process (GO:0009113) | 3.05419289 |
| 127 | IMP biosynthetic process (GO:0006188) | 3.04850554 |
| 128 | apoptotic DNA fragmentation (GO:0006309) | 3.04474118 |
| 129 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.03650965 |
| 130 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.03221970 |
| 131 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.00030896 |
| 132 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.99578515 |
| 133 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.98568767 |
| 134 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.98568767 |
| 135 | tRNA processing (GO:0008033) | 2.97034755 |
| 136 | histone exchange (GO:0043486) | 2.96288785 |
| 137 | replication fork processing (GO:0031297) | 2.95066115 |
| 138 | DNA replication initiation (GO:0006270) | 2.95048550 |
| 139 | establishment of integrated proviral latency (GO:0075713) | 2.94624255 |
| 140 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.94398512 |
| 141 | aerobic respiration (GO:0009060) | 2.94011867 |
| 142 | DNA strand elongation (GO:0022616) | 2.93843033 |
| 143 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.93427671 |
| 144 | mitochondrial DNA replication (GO:0006264) | 2.92852820 |
| 145 | microtubule severing (GO:0051013) | 2.92120403 |
| 146 | ubiquinone metabolic process (GO:0006743) | 2.91994955 |
| 147 | ATP biosynthetic process (GO:0006754) | 2.91294109 |
| 148 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.91189426 |
| 149 | intracellular protein transmembrane import (GO:0044743) | 2.90720238 |
| 150 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.89941946 |
| 151 | regulation of microtubule-based movement (GO:0060632) | 2.89392779 |
| 152 | nucleobase biosynthetic process (GO:0046112) | 2.88616488 |
| 153 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.87567530 |
| 154 | regulation of ligase activity (GO:0051340) | 2.87071702 |
| 155 | histone H4-K16 acetylation (GO:0043984) | 2.86128172 |
| 156 | GTP biosynthetic process (GO:0006183) | 2.85660097 |
| 157 | transcription from RNA polymerase I promoter (GO:0006360) | 2.85033382 |
| 158 | maintenance of protein localization in organelle (GO:0072595) | 2.84766863 |
| 159 | tRNA metabolic process (GO:0006399) | 2.83941774 |
| 160 | regulation of telomere maintenance (GO:0032204) | 2.83088308 |
| 161 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.82108218 |
| 162 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82098156 |
| 163 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82098156 |
| 164 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82098156 |
| 165 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.81811556 |
| 166 | mitochondrion distribution (GO:0048311) | 2.81284141 |
| 167 | cofactor transport (GO:0051181) | 2.80708612 |
| 168 | nuclear pore complex assembly (GO:0051292) | 2.80474638 |
| 169 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.78252509 |
| 170 | nucleoside transport (GO:0015858) | 2.75210356 |
| 171 | mitotic G2/M transition checkpoint (GO:0044818) | 2.73578267 |
| 172 | mitotic chromosome condensation (GO:0007076) | 2.72496759 |
| 173 | nuclear pore organization (GO:0006999) | 2.67949207 |
| 174 | rRNA processing (GO:0006364) | 2.64967088 |
| 175 | DNA duplex unwinding (GO:0032508) | 2.62074068 |
| 176 | DNA unwinding involved in DNA replication (GO:0006268) | 2.62037532 |
| 177 | cellular modified amino acid catabolic process (GO:0042219) | 2.61541720 |
| 178 | regulation of G0 to G1 transition (GO:0070316) | 2.60129248 |
| 179 | daunorubicin metabolic process (GO:0044597) | 10.4774529 |
| 180 | polyketide metabolic process (GO:0030638) | 10.4774529 |
| 181 | doxorubicin metabolic process (GO:0044598) | 10.4774529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.50748983 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.22659758 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.96720289 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.96720289 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.96720289 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.37350854 |
| 7 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.21107599 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.09545577 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.88593993 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.74902969 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.63727598 |
| 12 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.60034940 |
| 13 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.58746015 |
| 14 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.53359957 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.51779188 |
| 16 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49304903 |
| 17 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.48814302 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.48587193 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.45246481 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.39787090 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.38916369 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.35535585 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.33804175 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28294496 |
| 25 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.27872598 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.27243782 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.21507602 |
| 28 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.13524884 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.02767393 |
| 30 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 2.01462082 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.00151554 |
| 32 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.97113989 |
| 33 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.96467848 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.93543779 |
| 35 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.92905509 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91534553 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.90347009 |
| 38 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.89349273 |
| 39 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86220101 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.83193062 |
| 41 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.81287966 |
| 42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.78870913 |
| 43 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.76302661 |
| 44 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75770065 |
| 45 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.72057496 |
| 46 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69687831 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67139701 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66950575 |
| 49 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.66789060 |
| 50 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64763098 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.59296298 |
| 52 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58703349 |
| 53 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53680409 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52925706 |
| 55 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52910799 |
| 56 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.43820156 |
| 57 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.39715399 |
| 58 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39051172 |
| 59 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.37631292 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37500476 |
| 61 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.37148931 |
| 62 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.35561159 |
| 63 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.34525580 |
| 64 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32670310 |
| 65 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.32351813 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.31034064 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.30304267 |
| 68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29578298 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29013126 |
| 70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28230734 |
| 71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27287788 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25934153 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24853180 |
| 74 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24163161 |
| 75 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.23831499 |
| 76 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.23094253 |
| 77 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.22724138 |
| 78 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.22022322 |
| 79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20504458 |
| 80 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19250888 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18635522 |
| 82 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.14158234 |
| 83 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13897557 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13748308 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13574744 |
| 86 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13300359 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09976525 |
| 88 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.07980769 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07850980 |
| 90 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07413225 |
| 91 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07258642 |
| 92 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.05328772 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04431455 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03918570 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03638208 |
| 96 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.03297302 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02533031 |
| 98 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02274199 |
| 99 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.02183309 |
| 100 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01905984 |
| 101 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01104219 |
| 102 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99293726 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98157880 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96832103 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96682216 |
| 106 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96566338 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95311606 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94335180 |
| 109 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.93065138 |
| 110 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.92168491 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91741705 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91658279 |
| 113 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.90576537 |
| 114 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.88339420 |
| 115 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88236793 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88159933 |
| 117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87980980 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 0.87792471 |
| 119 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87569304 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86924022 |
| 121 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86473698 |
| 122 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.86310126 |
| 123 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85850500 |
| 124 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.85575983 |
| 125 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.84092826 |
| 126 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.81383129 |
| 127 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.78423924 |
| 128 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.76953537 |
| 129 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.73995189 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72894133 |
| 131 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.71441478 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71093132 |
| 133 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.70952763 |
| 134 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.68057691 |
| 135 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66917910 |
| 136 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.66328462 |
| 137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.66242607 |
| 138 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.65498574 |
| 139 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.65256940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.50768353 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.36945980 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.93992424 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.93073527 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.83859107 |
| 6 | MP0008057_abnormal_DNA_replication | 3.49901891 |
| 7 | MP0002254_reproductive_system_inflammat | 3.36696164 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 3.33064919 |
| 9 | MP0005499_abnormal_olfactory_system | 3.28422065 |
| 10 | MP0005394_taste/olfaction_phenotype | 3.28422065 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 3.21908568 |
| 12 | MP0003122_maternal_imprinting | 3.13471538 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 3.13228177 |
| 14 | MP0002332_abnormal_exercise_endurance | 3.05039786 |
| 15 | MP0009697_abnormal_copulation | 2.49807683 |
| 16 | MP0004858_abnormal_nervous_system | 2.44805641 |
| 17 | MP0003121_genomic_imprinting | 2.40735446 |
| 18 | MP0003646_muscle_fatigue | 2.30167651 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.20411923 |
| 20 | MP0003123_paternal_imprinting | 2.14906202 |
| 21 | MP0002277_abnormal_respiratory_mucosa | 2.11422693 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.08106708 |
| 23 | MP0003077_abnormal_cell_cycle | 2.05388831 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.93614497 |
| 25 | MP0000678_abnormal_parathyroid_gland | 1.86955574 |
| 26 | MP0003938_abnormal_ear_development | 1.84610026 |
| 27 | MP0003111_abnormal_nucleus_morphology | 1.84364571 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.80193182 |
| 29 | MP0005380_embryogenesis_phenotype | 1.79965228 |
| 30 | MP0001672_abnormal_embryogenesis/_devel | 1.79965228 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.75473324 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.75075787 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.73952722 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.72368446 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70982536 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.67811321 |
| 37 | MP0005266_abnormal_metabolism | 1.66922371 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.66014308 |
| 39 | MP0002088_abnormal_embryonic_growth/wei | 1.64732610 |
| 40 | MP0003984_embryonic_growth_retardation | 1.63966174 |
| 41 | MP0002160_abnormal_reproductive_system | 1.60819703 |
| 42 | MP0001764_abnormal_homeostasis | 1.59898055 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.53911973 |
| 44 | MP0000350_abnormal_cell_proliferation | 1.53002043 |
| 45 | MP0002938_white_spotting | 1.49871104 |
| 46 | MP0003195_calcinosis | 1.49374319 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.48441541 |
| 48 | MP0002132_abnormal_respiratory_system | 1.48258785 |
| 49 | MP0005330_cardiomyopathy | 1.48143726 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.43978273 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.43501648 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.40215241 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.40166628 |
| 54 | MP0008995_early_reproductive_senescence | 1.39544434 |
| 55 | MP0002102_abnormal_ear_morphology | 1.39129694 |
| 56 | MP0001293_anophthalmia | 1.37502363 |
| 57 | MP0004043_abnormal_pH_regulation | 1.35340452 |
| 58 | MP0003315_abnormal_perineum_morphology | 1.31870339 |
| 59 | MP0006082_CNS_inflammation | 1.30826606 |
| 60 | MP0000762_abnormal_tongue_morphology | 1.27948882 |
| 61 | MP0003137_abnormal_impulse_conducting | 1.27626077 |
| 62 | MP0009379_abnormal_foot_pigmentation | 1.27392030 |
| 63 | MP0002210_abnormal_sex_determination | 1.23427843 |
| 64 | MP0000049_abnormal_middle_ear | 1.23194246 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.23004308 |
| 66 | MP0003786_premature_aging | 1.21662841 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.21265532 |
| 68 | MP0004036_abnormal_muscle_relaxation | 1.20806768 |
| 69 | MP0001929_abnormal_gametogenesis | 1.19707363 |
| 70 | MP0001984_abnormal_olfaction | 1.15490432 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.15484000 |
| 72 | MP0005332_abnormal_amino_acid | 1.14267980 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.14237659 |
| 74 | MP0000490_abnormal_crypts_of | 1.13319098 |
| 75 | MP0001730_embryonic_growth_arrest | 1.13071539 |
| 76 | MP0002085_abnormal_embryonic_tissue | 1.12794604 |
| 77 | MP0004133_heterotaxia | 1.09306763 |
| 78 | MP0000313_abnormal_cell_death | 1.08655187 |
| 79 | MP0000749_muscle_degeneration | 1.08234961 |
| 80 | MP0008007_abnormal_cellular_replicative | 1.08093383 |
| 81 | MP0008058_abnormal_DNA_repair | 1.07849717 |
| 82 | MP0002234_abnormal_pharynx_morphology | 1.07414245 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.06805415 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06523404 |
| 85 | MP0002086_abnormal_extraembryonic_tissu | 1.05118543 |
| 86 | MP0002932_abnormal_joint_morphology | 1.04410526 |
| 87 | MP0003186_abnormal_redox_activity | 1.03931757 |
| 88 | MP0004381_abnormal_hair_follicle | 1.02454936 |
| 89 | MP0000358_abnormal_cell_content/ | 1.00141356 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.99854957 |
| 91 | MP0002233_abnormal_nose_morphology | 0.99303439 |
| 92 | MP0000653_abnormal_sex_gland | 0.98272692 |
| 93 | MP0002092_abnormal_eye_morphology | 0.97187314 |
| 94 | MP0005389_reproductive_system_phenotype | 0.96369293 |
| 95 | MP0005379_endocrine/exocrine_gland_phen | 0.96288926 |
| 96 | MP0003119_abnormal_digestive_system | 0.96131631 |
| 97 | MP0002114_abnormal_axial_skeleton | 0.95443288 |
| 98 | MP0001697_abnormal_embryo_size | 0.93170356 |
| 99 | MP0003941_abnormal_skin_development | 0.93039274 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.90583821 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.90420161 |
| 102 | MP0004147_increased_porphyrin_level | 0.90258172 |
| 103 | MP0005410_abnormal_fertilization | 0.89838482 |
| 104 | MP0002090_abnormal_vision | 0.88170386 |
| 105 | MP0004142_abnormal_muscle_tone | 0.87845713 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.87802754 |
| 107 | MP0002080_prenatal_lethality | 0.87779469 |
| 108 | MP0002163_abnormal_gland_morphology | 0.87546779 |
| 109 | MP0003787_abnormal_imprinting | 0.85680199 |
| 110 | MP0003698_abnormal_male_reproductive | 0.85524084 |
| 111 | MP0002084_abnormal_developmental_patter | 0.84741162 |
| 112 | MP0002970_abnormal_white_adipose | 0.84635407 |
| 113 | MP0003718_maternal_effect | 0.83812724 |
| 114 | MP0001661_extended_life_span | 0.83323427 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.82704283 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.82083070 |
| 117 | MP0008872_abnormal_physiological_respon | 0.81917592 |
| 118 | MP0002269_muscular_atrophy | 0.78611339 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.78014681 |
| 120 | MP0001849_ear_inflammation | 0.77816874 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.75249506 |
| 122 | MP0005408_hypopigmentation | 0.74750149 |
| 123 | MP0003755_abnormal_palate_morphology | 0.73687486 |
| 124 | MP0005391_vision/eye_phenotype | 0.73066017 |
| 125 | MP0001529_abnormal_vocalization | 0.72125852 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.71500041 |
| 127 | MP0006276_abnormal_autonomic_nervous | 0.70991781 |
| 128 | MP0000631_abnormal_neuroendocrine_gland | 0.70871159 |
| 129 | MP0000432_abnormal_head_morphology | 0.69379720 |
| 130 | MP0001919_abnormal_reproductive_system | 0.69014464 |
| 131 | MP0008770_decreased_survivor_rate | 0.68142252 |
| 132 | MP0001119_abnormal_female_reproductive | 0.67997482 |
| 133 | MP0005395_other_phenotype | 0.67889347 |
| 134 | MP0003136_yellow_coat_color | 0.67286138 |
| 135 | MP0009046_muscle_twitch | 0.67018541 |
| 136 | MP0005360_urolithiasis | 0.65296049 |
| 137 | MP0001905_abnormal_dopamine_level | 0.64614479 |
| 138 | MP0003937_abnormal_limbs/digits/tail_de | 0.64580345 |
| 139 | MP0000516_abnormal_urinary_system | 0.62777261 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.62777261 |
| 141 | MP0003705_abnormal_hypodermis_morpholog | 0.60670113 |
| 142 | MP0004197_abnormal_fetal_growth/weight/ | 0.59988262 |
| 143 | MP0000428_abnormal_craniofacial_morphol | 0.57977753 |
| 144 | MP0002019_abnormal_tumor_incidence | 0.56620941 |
| 145 | MP0003935_abnormal_craniofacial_develop | 0.55880037 |
| 146 | MP0001145_abnormal_male_reproductive | 0.55860492 |
| 147 | MP0001286_abnormal_eye_development | 0.53902219 |
| 148 | MP0005384_cellular_phenotype | 0.53744268 |
| 149 | MP0005253_abnormal_eye_physiology | 0.52730058 |
| 150 | MP0000372_irregular_coat_pigmentation | 0.51884654 |
| 151 | MP0004782_abnormal_surfactant_physiolog | 0.51879048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.70821176 |
| 2 | Multiple enchondromatosis (HP:0005701) | 5.51531663 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 5.29469559 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.87496815 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.49552880 |
| 6 | Hepatoblastoma (HP:0002884) | 4.37526168 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.36740722 |
| 8 | Lipid accumulation in hepatocytes (HP:0006561) | 4.31427602 |
| 9 | Hepatic necrosis (HP:0002605) | 4.29283249 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.29235313 |
| 11 | Cerebral edema (HP:0002181) | 4.05047512 |
| 12 | Rib fusion (HP:0000902) | 3.99869024 |
| 13 | Abnormality of glycolysis (HP:0004366) | 3.76234045 |
| 14 | Increased serum pyruvate (HP:0003542) | 3.76234045 |
| 15 | Abnormality of the lower motor neuron (HP:0002366) | 3.75007829 |
| 16 | Ependymoma (HP:0002888) | 3.73427498 |
| 17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.72083324 |
| 18 | Rhabdomyosarcoma (HP:0002859) | 3.66288828 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.62893147 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.62893147 |
| 21 | Ragged-red muscle fibers (HP:0003200) | 3.60838693 |
| 22 | Rectovaginal fistula (HP:0000143) | 3.58028350 |
| 23 | Rectal fistula (HP:0100590) | 3.58028350 |
| 24 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.54691128 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.49757588 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.49619298 |
| 27 | Testicular atrophy (HP:0000029) | 3.45308590 |
| 28 | Neoplasm of striated muscle (HP:0009728) | 3.42800519 |
| 29 | Increased intramyocellular lipid droplets (HP:0012240) | 3.41392869 |
| 30 | Chromsome breakage (HP:0040012) | 3.41309790 |
| 31 | Lactic acidosis (HP:0003128) | 3.34969114 |
| 32 | Partial duplication of thumb phalanx (HP:0009944) | 3.32798802 |
| 33 | Trismus (HP:0000211) | 3.32737063 |
| 34 | Embryonal renal neoplasm (HP:0011794) | 3.26483087 |
| 35 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.25674436 |
| 36 | Hypoplasia of the fovea (HP:0007750) | 3.25674436 |
| 37 | Microvesicular hepatic steatosis (HP:0001414) | 3.10321394 |
| 38 | Increased muscle lipid content (HP:0009058) | 3.10277705 |
| 39 | Exercise intolerance (HP:0003546) | 3.08439710 |
| 40 | Abnormal lung lobation (HP:0002101) | 3.07838363 |
| 41 | Vaginal fistula (HP:0004320) | 2.98526306 |
| 42 | Intestinal fistula (HP:0100819) | 2.96053231 |
| 43 | Fused cervical vertebrae (HP:0002949) | 2.93210055 |
| 44 | Reduced antithrombin III activity (HP:0001976) | 2.91657434 |
| 45 | Anomalous pulmonary venous return (HP:0010772) | 2.89668174 |
| 46 | Respiratory failure (HP:0002878) | 2.87305357 |
| 47 | Bifid tongue (HP:0010297) | 2.82887143 |
| 48 | Partial duplication of the phalanx of hand (HP:0009999) | 2.82753057 |
| 49 | Progressive external ophthalmoplegia (HP:0000590) | 2.78630442 |
| 50 | Microretrognathia (HP:0000308) | 2.74221228 |
| 51 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.73426482 |
| 52 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.72754276 |
| 53 | Abnormal cartilage morphology (HP:0002763) | 2.72587104 |
| 54 | Sensory axonal neuropathy (HP:0003390) | 2.72394972 |
| 55 | Hyperventilation (HP:0002883) | 2.71124134 |
| 56 | Impulsivity (HP:0100710) | 2.68873906 |
| 57 | Amyotrophic lateral sclerosis (HP:0007354) | 2.67511725 |
| 58 | Abnormal glycosylation (HP:0012345) | 2.65953941 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65953941 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65953941 |
| 61 | Abnormal protein glycosylation (HP:0012346) | 2.65953941 |
| 62 | Lethargy (HP:0001254) | 2.64782539 |
| 63 | Meckel diverticulum (HP:0002245) | 2.64626168 |
| 64 | Progressive muscle weakness (HP:0003323) | 2.59545078 |
| 65 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.57028254 |
| 66 | Optic disc pallor (HP:0000543) | 2.54846549 |
| 67 | Horizontal nystagmus (HP:0000666) | 2.54630386 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 2.54103973 |
| 69 | Supernumerary spleens (HP:0009799) | 2.52050271 |
| 70 | Abnormality of the salivary glands (HP:0010286) | 2.51915690 |
| 71 | Hyperglycinemia (HP:0002154) | 2.50335791 |
| 72 | CNS demyelination (HP:0007305) | 2.48526092 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.47317857 |
| 74 | Exertional dyspnea (HP:0002875) | 2.47262137 |
| 75 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.46929708 |
| 76 | Abnormality of the ileum (HP:0001549) | 2.46786583 |
| 77 | Leukodystrophy (HP:0002415) | 2.45259696 |
| 78 | Short humerus (HP:0005792) | 2.44415123 |
| 79 | Glossoptosis (HP:0000162) | 2.44382905 |
| 80 | Aplastic anemia (HP:0001915) | 2.43568533 |
| 81 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.43247339 |
| 82 | Nasolacrimal duct obstruction (HP:0000579) | 2.42724978 |
| 83 | Abnormality of the pulmonary veins (HP:0011718) | 2.42488130 |
| 84 | Premature ovarian failure (HP:0008209) | 2.39363189 |
| 85 | Type I transferrin isoform profile (HP:0003642) | 2.38638748 |
| 86 | Abnormality of the fovea (HP:0000493) | 2.36263215 |
| 87 | Respiratory difficulties (HP:0002880) | 2.35760138 |
| 88 | Colon cancer (HP:0003003) | 2.32685720 |
| 89 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.31429881 |
| 90 | Tongue fasciculations (HP:0001308) | 2.29939539 |
| 91 | Abnormality of the astrocytes (HP:0100707) | 2.26613066 |
| 92 | Astrocytoma (HP:0009592) | 2.26613066 |
| 93 | Acute necrotizing encephalopathy (HP:0006965) | 2.25584305 |
| 94 | Reticulocytopenia (HP:0001896) | 2.25474637 |
| 95 | Abnormality of alanine metabolism (HP:0010916) | 2.24444723 |
| 96 | Hyperalaninemia (HP:0003348) | 2.24444723 |
| 97 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.24444723 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 2.23716196 |
| 99 | Glycosuria (HP:0003076) | 2.23716196 |
| 100 | Periauricular skin pits (HP:0100277) | 2.22822302 |
| 101 | Preauricular pit (HP:0004467) | 2.22822302 |
| 102 | Macrocytic anemia (HP:0001972) | 2.18605002 |
| 103 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.17312775 |
| 104 | Methylmalonic aciduria (HP:0012120) | 2.16912395 |
| 105 | Cheilitis (HP:0100825) | 2.16375121 |
| 106 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15236490 |
| 107 | Methylmalonic acidemia (HP:0002912) | 2.13722854 |
| 108 | Hyperglycinuria (HP:0003108) | 2.13519242 |
| 109 | Generalized hypotonia (HP:0001290) | 2.13255019 |
| 110 | Secondary amenorrhea (HP:0000869) | 2.11473538 |
| 111 | Absent thumb (HP:0009777) | 2.11259293 |
| 112 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.10831583 |
| 113 | Hypoglycemic coma (HP:0001325) | 2.09723293 |
| 114 | Preauricular skin tag (HP:0000384) | 2.07980194 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07775655 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 2.07775655 |
| 117 | Pancytopenia (HP:0001876) | 2.06848893 |
| 118 | Abnormality of serum amino acid levels (HP:0003112) | 2.06342951 |
| 119 | Abnormality of the preputium (HP:0100587) | 2.06002826 |
| 120 | Hypochromic anemia (HP:0001931) | 2.05598782 |
| 121 | Molar tooth sign on MRI (HP:0002419) | 2.05353490 |
| 122 | Abnormality of midbrain morphology (HP:0002418) | 2.05353490 |
| 123 | Muscle fibrillation (HP:0010546) | 2.05314014 |
| 124 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.04827123 |
| 125 | Villous atrophy (HP:0011473) | 2.04827123 |
| 126 | Facial cleft (HP:0002006) | 2.04573518 |
| 127 | Duodenal stenosis (HP:0100867) | 2.04356731 |
| 128 | Small intestinal stenosis (HP:0012848) | 2.04356731 |
| 129 | Tetraplegia (HP:0002445) | 2.01267147 |
| 130 | Shawl scrotum (HP:0000049) | 2.00940079 |
| 131 | Increased CSF lactate (HP:0002490) | 2.00852543 |
| 132 | Abnormal biliary tract physiology (HP:0012439) | 1.99501948 |
| 133 | Bile duct proliferation (HP:0001408) | 1.99501948 |
| 134 | Pancreatic cysts (HP:0001737) | 1.97655771 |
| 135 | Duplication of thumb phalanx (HP:0009942) | 1.97311877 |
| 136 | Abnormality of renal resorption (HP:0011038) | 1.97255853 |
| 137 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97135503 |
| 138 | Pancreatic fibrosis (HP:0100732) | 1.96825856 |
| 139 | Sparse eyelashes (HP:0000653) | 1.95808967 |
| 140 | CNS hypomyelination (HP:0003429) | 1.95111686 |
| 141 | Malnutrition (HP:0004395) | 1.94662807 |
| 142 | Adenoma sebaceum (HP:0009720) | 1.94627040 |
| 143 | Angiofibromas (HP:0010615) | 1.94627040 |
| 144 | Combined immunodeficiency (HP:0005387) | 1.92319729 |
| 145 | Abnormality of methionine metabolism (HP:0010901) | 1.92169004 |
| 146 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92081437 |
| 147 | Abnormality of glycine metabolism (HP:0010895) | 1.92081437 |
| 148 | Nausea (HP:0002018) | 1.91240484 |
| 149 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.90974808 |
| 150 | Pendular nystagmus (HP:0012043) | 1.90521981 |
| 151 | True hermaphroditism (HP:0010459) | 1.89896052 |
| 152 | Emotional lability (HP:0000712) | 1.89768544 |
| 153 | Hypoplasia of the pons (HP:0012110) | 1.89766821 |
| 154 | Medulloblastoma (HP:0002885) | 1.89368459 |
| 155 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.88762270 |
| 156 | Abnormality of the labia minora (HP:0012880) | 1.86940132 |
| 157 | Acute encephalopathy (HP:0006846) | 1.83636166 |
| 158 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.82143202 |
| 159 | Birth length less than 3rd percentile (HP:0003561) | 1.81926088 |
| 160 | Increased serum lactate (HP:0002151) | 1.81489572 |
| 161 | Abnormality of chromosome segregation (HP:0002916) | 1.80671853 |
| 162 | Abnormality of chromosome stability (HP:0003220) | 1.80217229 |
| 163 | Cerebral hypomyelination (HP:0006808) | 1.80183560 |
| 164 | Breast hypoplasia (HP:0003187) | 1.79409654 |
| 165 | Hyperphosphaturia (HP:0003109) | 1.75549728 |
| 166 | Carpal bone hypoplasia (HP:0001498) | 1.72307143 |
| 167 | X-linked dominant inheritance (HP:0001423) | 1.72225893 |
| 168 | Progressive microcephaly (HP:0000253) | 1.68658251 |
| 169 | Vomiting (HP:0002013) | 1.67883759 |
| 170 | Neoplasm of the adrenal gland (HP:0100631) | 1.67298201 |
| 171 | Degeneration of anterior horn cells (HP:0002398) | 1.67048208 |
| 172 | Abnormality of the anterior horn cell (HP:0006802) | 1.67048208 |
| 173 | Abnormality of the pons (HP:0007361) | 1.66644330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.10379360 |
| 2 | GRK5 | 5.57022349 |
| 3 | GRK6 | 4.21665344 |
| 4 | VRK2 | 4.02078410 |
| 5 | ADRBK2 | 3.46551934 |
| 6 | ERN1 | 3.40201262 |
| 7 | GRK1 | 3.19233709 |
| 8 | TTK | 3.07785528 |
| 9 | ZAK | 3.05542474 |
| 10 | GRK7 | 2.91050350 |
| 11 | CSF1R | 2.70725404 |
| 12 | BUB1 | 2.69818471 |
| 13 | PINK1 | 2.51276619 |
| 14 | NUAK1 | 2.10434204 |
| 15 | MAPK7 | 2.05704969 |
| 16 | MATK | 2.04953982 |
| 17 | TGFBR2 | 2.01388230 |
| 18 | MOS | 1.91122800 |
| 19 | TYRO3 | 1.86116220 |
| 20 | BMPR1B | 1.77761450 |
| 21 | STK10 | 1.75419106 |
| 22 | TRIM28 | 1.70488239 |
| 23 | OBSCN | 1.63001628 |
| 24 | CDK7 | 1.61150651 |
| 25 | WEE1 | 1.60027690 |
| 26 | PLK1 | 1.59573330 |
| 27 | PRKG2 | 1.58551069 |
| 28 | WNK1 | 1.56723053 |
| 29 | AKT3 | 1.47105888 |
| 30 | CHEK2 | 1.45831646 |
| 31 | EPHA2 | 1.28308959 |
| 32 | NME2 | 1.26647762 |
| 33 | TAF1 | 1.26591682 |
| 34 | WNK3 | 1.22386638 |
| 35 | EIF2AK1 | 1.22237275 |
| 36 | STK16 | 1.21840772 |
| 37 | ADRBK1 | 1.19119503 |
| 38 | CAMK4 | 1.16744151 |
| 39 | SRPK1 | 1.16044129 |
| 40 | CSNK1G3 | 1.10725908 |
| 41 | NTRK1 | 1.09967887 |
| 42 | PAK4 | 1.08253108 |
| 43 | MAP2K4 | 1.05859809 |
| 44 | MAP4K2 | 1.05005015 |
| 45 | MKNK2 | 1.02462523 |
| 46 | NME1 | 1.02361451 |
| 47 | MAP2K7 | 1.00896505 |
| 48 | EIF2AK2 | 0.97866781 |
| 49 | CSNK1G1 | 0.95600457 |
| 50 | MKNK1 | 0.94301844 |
| 51 | CDC7 | 0.94292314 |
| 52 | FRK | 0.91880246 |
| 53 | AURKA | 0.91184531 |
| 54 | CSNK1A1L | 0.90662917 |
| 55 | CSNK1G2 | 0.86033374 |
| 56 | MUSK | 0.83393962 |
| 57 | MAP2K6 | 0.82674533 |
| 58 | MARK3 | 0.82368752 |
| 59 | CHEK1 | 0.79881904 |
| 60 | VRK1 | 0.76903717 |
| 61 | TESK2 | 0.75847554 |
| 62 | TIE1 | 0.75014199 |
| 63 | MAP3K12 | 0.74824522 |
| 64 | TNIK | 0.74430737 |
| 65 | MARK2 | 0.73502171 |
| 66 | PHKG2 | 0.71379678 |
| 67 | PHKG1 | 0.71379678 |
| 68 | PRKCI | 0.70433240 |
| 69 | DYRK2 | 0.70431599 |
| 70 | INSRR | 0.70319141 |
| 71 | RPS6KA5 | 0.69259773 |
| 72 | MST4 | 0.68951671 |
| 73 | AURKB | 0.67129044 |
| 74 | AKT2 | 0.64584109 |
| 75 | NEK1 | 0.61113069 |
| 76 | TLK1 | 0.61007473 |
| 77 | CDK8 | 0.60664021 |
| 78 | HIPK2 | 0.59560955 |
| 79 | EIF2AK3 | 0.58579084 |
| 80 | STK4 | 0.57581660 |
| 81 | NEK2 | 0.56875562 |
| 82 | KDR | 0.54837314 |
| 83 | MAP3K10 | 0.54391394 |
| 84 | PLK2 | 0.54192240 |
| 85 | DAPK3 | 0.53613821 |
| 86 | RPS6KA4 | 0.53328885 |
| 87 | MAPK12 | 0.52582333 |
| 88 | PAK1 | 0.52438510 |
| 89 | RPS6KB2 | 0.50427107 |
| 90 | MINK1 | 0.49597007 |
| 91 | DAPK1 | 0.47879367 |
| 92 | BRSK2 | 0.47775659 |
| 93 | BCR | 0.47743557 |
| 94 | PDK4 | 0.47123194 |
| 95 | PDK3 | 0.47123194 |
| 96 | ERBB3 | 0.46849976 |
| 97 | CDK2 | 0.46687616 |
| 98 | MAP3K5 | 0.45664389 |
| 99 | BCKDK | 0.45503085 |
| 100 | MAPKAPK3 | 0.45410240 |
| 101 | PLK4 | 0.45403700 |
| 102 | ARAF | 0.44544432 |
| 103 | ALK | 0.44106006 |
| 104 | LIMK1 | 0.44067554 |
| 105 | STK39 | 0.43685194 |
| 106 | MYLK | 0.40451546 |
| 107 | MAPK13 | 0.38824608 |
| 108 | OXSR1 | 0.38468470 |
| 109 | CCNB1 | 0.37617522 |
| 110 | BRAF | 0.37589107 |
| 111 | CDK15 | 0.36316735 |
| 112 | CDK18 | 0.36268943 |
| 113 | CDK11A | 0.36222390 |
| 114 | ATM | 0.35596031 |
| 115 | CSNK1A1 | 0.35510401 |
| 116 | CSNK1E | 0.35500833 |
| 117 | LATS2 | 0.34750405 |
| 118 | DYRK3 | 0.34504740 |
| 119 | PRKCD | 0.34502267 |
| 120 | FGFR3 | 0.34095859 |
| 121 | TSSK6 | 0.32341263 |
| 122 | BRSK1 | 0.31334171 |
| 123 | ILK | 0.30504117 |
| 124 | PIM2 | 0.30489988 |
| 125 | ACVR1B | 0.30468480 |
| 126 | CSNK2A1 | 0.30136532 |
| 127 | PRKCG | 0.30108023 |
| 128 | CSK | 0.29915580 |
| 129 | CDK1 | 0.29551377 |
| 130 | STK3 | 0.28482984 |
| 131 | CDK3 | 0.28463039 |
| 132 | MAPK4 | 0.27621643 |
| 133 | PDK2 | 0.26836592 |
| 134 | IGF1R | 0.26113447 |
| 135 | CDK14 | 0.25417863 |
| 136 | CDK19 | 0.25206766 |
| 137 | STK38L | 0.24983386 |
| 138 | PRKACA | 0.23076170 |
| 139 | CDK4 | 0.22861340 |
| 140 | IKBKB | 0.22671405 |
| 141 | PLK3 | 0.22239153 |
| 142 | CSNK2A2 | 0.21746075 |
| 143 | DYRK1A | 0.20686396 |
| 144 | ABL2 | 0.20330646 |
| 145 | ATR | 0.19857937 |
| 146 | PRKACB | 0.17828894 |
| 147 | PBK | 0.16825858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.36615287 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.43126896 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.00479559 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.69818618 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.08665354 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.96019674 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.89620401 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.88631054 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52840046 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.42043135 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.34505455 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.24542944 |
| 13 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.13150679 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.02603186 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.96106817 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.88632856 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.86345854 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84585278 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.77305455 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76586795 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.72020838 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.69181252 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66576578 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63791868 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61742732 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.56208953 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.55994061 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.42563731 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39432230 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.38512276 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.37866505 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35969318 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.31695704 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27691841 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26924409 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26809816 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15113248 |
| 38 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.14960550 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08007740 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06963491 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05653305 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01772263 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.97163115 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93380699 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92935677 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88470684 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82056751 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81569259 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81001713 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79021129 |
| 51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76835877 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.76343159 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74833536 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74612262 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72251221 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71247542 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68556689 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68468368 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68303748 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64770225 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64352116 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63930811 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63841155 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63176098 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62055176 |
| 66 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60243953 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58226901 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58213936 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56578359 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55718486 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55508752 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53927966 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53340230 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52045885 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51465982 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51363939 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50661282 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49781729 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49180314 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.46908952 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46708364 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46612214 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46172242 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45537910 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45296271 |
| 86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42118629 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.42069646 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38824729 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37315273 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37272409 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35324736 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33555170 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31559112 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31263691 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29501027 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.24004282 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24001436 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22874618 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22051644 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.21231245 |
| 101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21074072 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19074067 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18739299 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.18734692 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.18151955 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17972054 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.17933921 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17740522 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17480247 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17156990 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.15881280 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15788450 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.15614331 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15060824 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14747096 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.12610692 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.12421242 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11644419 |
| 119 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.11125867 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10093816 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.08879631 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.08848468 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.05013423 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.03793283 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03374615 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03287838 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02728294 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.02021586 |
| 129 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.01089813 |

